Meiji to separate out pharma ops in major restructuring
This article was originally published in Scrip
Executive Summary
The diversified Japanese group Meiji Holdings is to separate out its pharmaceutical operations next year as part of a wider restructuring aimed at increasing the flexibility and independence of its various businesses.